Jeffrey L. Garwin
Founder at UltraTouch Corp.
Profile
Jeffrey L.
Garwin is the founder and holds the title of President, Secretary & Treasurer at UltraTouch Corp.
which is founded in 1998.
He also held the position of Director at Biomoda, Inc. and Chief Medical Officer at Ritter Pharmaceuticals, Inc. Dr. Garwin received his undergraduate degree from Stanford University and his doctorate from Yale University.
Jeffrey L. Garwin active positions
| Companies | Position | Start |
|---|---|---|
UltraTouch Corp.
 UltraTouch Corp. Medical SpecialtiesHealth Technology UltraTouch Corp. develops precision breast palpation technology for documentation of palpation exams in the medical record. It offers Palpagraph, a breast tumor detection device to store the data for the medical record. The company was founded by Jeffrey L. Garwin in 1998 and is headquartered in Paoli, PA. | Founder | 31/12/1997 |
Former positions of Jeffrey L. Garwin
| Companies | Position | End |
|---|---|---|
| QUALIGEN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| BIOMODA, INC. | Director/Board Member | - |
Training of Jeffrey L. Garwin
| Yale University | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Biomoda, Inc.
 Biomoda, Inc. Medical/Nursing ServicesHealth Services Biomoda, inc. operates as an in-vitro diagnostics company. The company was founded on January 3, 1990 and is headquartered in Albuquerque, NM. | Health Services |
UltraTouch Corp.
UltraTouch Corp. Medical SpecialtiesHealth Technology UltraTouch Corp. develops precision breast palpation technology for documentation of palpation exams in the medical record. It offers Palpagraph, a breast tumor detection device to store the data for the medical record. The company was founded by Jeffrey L. Garwin in 1998 and is headquartered in Paoli, PA. | Health Technology |
Ritter Pharmaceuticals, Inc.
 Ritter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey L. Garwin
